Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Crispr Therapeutics: Poised For A Major Turnaround
06:36am, Monday, 28'th Oct 2024
Crispr Therapeutics, a leader in CRISPR/Cas9 biotechnology, recently received FDA and EMA approval for Casgevy, the first CRISPR/Cas9-based treatment for TDT and SCD. The partnership with Vertex Pharm
The Ultimate Biotech Stock to Buy With $50 Right Now
06:32am, Saturday, 26'th Oct 2024
This company might be worth far more than many realize.
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
06:55pm, Friday, 25'th Oct 2024
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $47.36, representing a -1.23% change from its previous close.
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
10:11am, Thursday, 24'th Oct 2024
New drug approvals and strong pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position EXEL, B
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:50am, Tuesday, 22'nd Oct 2024
The aggressive growth icon kicked off the new trading week by buying some of her favorite stocks.
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
07:06pm, Monday, 21'st Oct 2024
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $48.51, indicating a -0.84% shift from the previous trading day.
Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?
10:55am, Monday, 21'st Oct 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 67.5% in CRISPR Therapeutics (CRSP). While the effectiveness of this highly sought-after metric is questionable
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
07:30am, Saturday, 19'th Oct 2024
Yes, bargains can still be found in the stock market.
Why I Keep Buying These 14 Incredible Growth Stocks
09:45am, Wednesday, 16'th Oct 2024
This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors
07:06pm, Tuesday, 15'th Oct 2024
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $48.05, representing a +0.47% change from its previous close.
Is CRISPR Therapeutics Stock a Buy?
06:30am, Sunday, 13'th Oct 2024
The markets this biotech is looking to enter could be extremely lucrative.
2 Biotech Stocks That Are Screaming Buys This Month
08:30am, Saturday, 12'th Oct 2024
They won't remain southbound forever.
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
07:06pm, Tuesday, 08'th Oct 2024
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $45.20, marking a -0.64% move from the previous day.
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
04:25am, Saturday, 05'th Oct 2024
CRISPR Therapeutics is trading around multiyear lows.
Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today
07:06pm, Wednesday, 02'nd Oct 2024
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $45.71, indicating a +0.29% shift from the previous trading day.
